• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人红细胞尿卟啉原脱羧酶的一些动力学特性。

Some kinetic properties of human red cell uroporphyrinogen decarboxylase.

作者信息

de Verneuil H, Grandchamp B, Nordmann Y

出版信息

Biochim Biophys Acta. 1980 Jan 11;611(1):174-86. doi: 10.1016/0005-2744(80)90053-4.

DOI:10.1016/0005-2744(80)90053-4
PMID:7350915
Abstract

Several kinetic properties of uroporphyrinogen decarboxylase (uroporphyrinogen-III carboxy-lyase, EC 4.1.1.37) from human hemoglobin-free hemolysates were studied, using substrates of both isomeric series I and III (uroporphyrinogen, hepta and pentacarboxyl porphyrinogens). Enzyme affinity for series II isomers was always found to be higher than for corresponding series I isomers. Mixed substrate experiments using porphyrinogen (both labelled with 14C and unlabelled) showed: (a) a reciprocal inhibition of decarboxylation of series III porphyrinogens by series I porphyrinogens with the same number of carboxylic groups; (b) no inhibition of hepta- and pentacarboxylic series III porphyrinogens decarboxylation by uroporphyrinogen III. It is demonstrated that porphyrinogens of both isomeric series with the same number of carboxylic groups are decarboxylated at the same active center; in contrast, the sequential decarboxylation of uroporphyrinogen III to coproporphyrinogen III occurs at four different active centers. Relationship between the kinetic properties of uroporphyrinogen decarboxylase and biological data of porphyria cutanea are discussed.

摘要

利用Ⅰ型和Ⅲ型异构体系列的底物(尿卟啉原、七羧基和五羧基卟啉原),研究了来自无血红蛋白人溶血产物的尿卟啉原脱羧酶(尿卟啉原-Ⅲ羧基裂解酶,EC 4.1.1.37)的几种动力学性质。发现该酶对Ⅱ型异构体的亲和力总是高于相应的Ⅰ型异构体。使用卟啉原(既有14C标记的,也有未标记的)进行的混合底物实验表明:(a)具有相同羧基数目的Ⅰ型卟啉原对Ⅲ型卟啉原的脱羧反应有相互抑制作用;(b)尿卟啉原Ⅲ对七羧基和五羧基系列Ⅲ型卟啉原的脱羧反应无抑制作用。结果表明,具有相同羧基数目的两种异构体系列的卟啉原在同一活性中心进行脱羧反应;相反,尿卟啉原Ⅲ依次脱羧生成粪卟啉原Ⅲ是在四个不同的活性中心进行的。本文还讨论了尿卟啉原脱羧酶的动力学性质与迟发性皮肤卟啉症生物学数据之间的关系。

相似文献

1
Some kinetic properties of human red cell uroporphyrinogen decarboxylase.人红细胞尿卟啉原脱羧酶的一些动力学特性。
Biochim Biophys Acta. 1980 Jan 11;611(1):174-86. doi: 10.1016/0005-2744(80)90053-4.
2
Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.迟发性皮肤卟啉症及某些其他人类卟啉症中的红细胞卟啉原羧基裂解酶活性
Clin Chim Acta. 1980 Dec 22;108(3):447-56. doi: 10.1016/0009-8981(80)90352-6.
3
Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.大鼠肝脏尿卟啉原脱羧酶的研究。卟啉原I和III作为底物的比较以及卟啉的抑制作用。
Biochem J. 1981 Apr 1;195(1):241-50. doi: 10.1042/bj1950241.
4
Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.对人红细胞尿卟啉原脱羧酶的底物亲和力降低构成迟发性皮肤卟啉症的内在生化缺陷。
Biochem Biophys Res Commun. 1985 Mar 15;127(2):517-25. doi: 10.1016/s0006-291x(85)80190-x.
5
Decarboxylation of uroporphyrinogen III by erythrocyte uroporphyrinogen decarboxylase. Evidence for a random decarboxylation mechanism.红细胞尿卟啉原脱羧酶对尿卟啉原III的脱羧作用。随机脱羧机制的证据。
Biochem J. 1990 Jun 1;268(2):513-5. doi: 10.1042/bj2680513.
6
Order of uroporphyrinogen III decarboxylation on incubation of porphobilinogen and uroporphyrinogen III with erythrocyte uroporphyrinogen decarboxylase.在将胆色素原和尿卟啉原III与红细胞尿卟啉原脱羧酶一起孵育时尿卟啉原III脱羧的顺序
Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):529-32. doi: 10.1042/bj2890529.
7
In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.在厌氧条件下亚铁离子对大鼠肝脏尿卟啉原脱羧酶活性抑制机制的体外研究
Arch Biochem Biophys. 1986 Feb 1;244(2):619-29. doi: 10.1016/0003-9861(86)90630-2.
8
Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?迟发性皮肤卟啉病家族中人类红细胞尿卟啉原脱羧酶缺陷:是代谢病变还是内源性卟啉血症的结果?
Biochem Biophys Res Commun. 1988 Jul 15;154(1):39-46. doi: 10.1016/0006-291x(88)90646-8.
9
Decarboxylation of uroporphyrinogen I and III in 2,3,7,8-tetrachlorodibenzo-p-dioxin induced porphyria in mice.2,3,7,8-四氯二苯并对二恶英诱导的小鼠卟啉症中尿卟啉原I和III的脱羧作用
Int J Biochem. 1984;16(5):561-5. doi: 10.1016/0020-711x(84)90175-7.
10
Tetrapyrroles as substrates and inhibitors of porphyrinogen carboxy - lyase from rat liver.四吡咯作为大鼠肝脏中卟啉原羧化酶的底物和抑制剂
Acta Physiol Lat Am. 1976;26(5):403-14.

引用本文的文献

1
mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks.基于信使核糖核酸的疗法在混合型卟啉病兔模型中为急性发作的发病机制提供了新见解。
Mol Ther Nucleic Acids. 2021 May 19;25:207-219. doi: 10.1016/j.omtn.2021.05.010. eCollection 2021 Sep 3.
2
Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.突变型人尿卟啉原脱羧酶的结构与动力学特性
Cell Mol Biol (Noisy-le-grand). 2009 Jul 1;55(2):40-5.
3
Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogen.
生成粪卟啉原无需尿卟啉原脱羧酶活性位点之间的底物穿梭。
J Mol Biol. 2009 Jun 5;389(2):306-14. doi: 10.1016/j.jmb.2009.04.013. Epub 2009 Apr 10.
4
Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.家族性迟发性皮肤卟啉症:7种新型尿卟啉原脱羧酶突变的特征及常见血色素沉着症等位基因的频率
Am J Hum Genet. 1998 Nov;63(5):1363-75. doi: 10.1086/302119.
5
Crystal structure of human uroporphyrinogen decarboxylase.人尿卟啉原脱羧酶的晶体结构
EMBO J. 1998 May 1;17(9):2463-71. doi: 10.1093/emboj/17.9.2463.
6
Uroporphyrinogen decarboxylase.尿卟啉原脱羧酶
J Bioenerg Biomembr. 1995 Apr;27(2):207-14. doi: 10.1007/BF02110035.
7
Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.大鼠肝脏尿卟啉原脱羧酶的研究。卟啉原I和III作为底物的比较以及卟啉的抑制作用。
Biochem J. 1981 Apr 1;195(1):241-50. doi: 10.1042/bj1950241.
8
Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver.人红细胞中尿卟啉原脱羧酶的纯化。人红细胞和肝脏中具有脱羧酶活性的单一蛋白质的免疫化学证据。
Biochem J. 1983 Oct 1;215(1):45-55. doi: 10.1042/bj2150045.
9
Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.迟发性皮肤卟啉症和肝红细胞生成性卟啉症中尿卟啉原脱羧酶的酶学和免疫学研究
Am J Hum Genet. 1984 May;36(3):613-22.
10
Modified uroporphyrinogen decarboxylase activity in a yeast mutant which mimics porphyria cutanea tarda.模拟迟发性皮肤卟啉症的酵母突变体中修饰的尿卟啉原脱羧酶活性
Biochem J. 1984 Mar 1;218(2):405-13. doi: 10.1042/bj2180405.